Tag: FDA
Sabinsa Researcher Gives Seminar to FDA Scientists
East Windsor, NJ—Dr. Kalyanam Nagabhushanam, President, R&D, Sabinsa, presented a seminar to a group of FDA scientists as part of the CDER Botanical Drug...
Interim FDA Commissioner Floated; HHS Secretary Resigns
Silver Spring, MD—Janet Woodcock, M.D., is expected to serve as interim FDA Commissioner, according to Bloomberg, and Alex Azar has resigned as Health &...
FDA Releases Update on CBD; CRN Calls It an “End-of-Administration Desk-Clearing Exercise”
Silver Spring, MD—In response to accusations of lack of movement on the cannabidiol (CBD) front, FDA has released a statement titled “Better Data for...
NPA Raises Issues of CBD and Counterfeit Products in Letter to Congress
Washington, D.C.—The National Products Association (NPA) has welcomed new Congress members with a letter expressing concern regarding the lack of action from the FDA...
FDA Finds Adulterated Products on Amazon, eBay
Silver Spring, MD—FDA is warning consumers not to use nearly 50 male enhancement or weight loss products purchased through Amazon and eBay, as they...
FDA Issues Warning Letter to Whole Foods Market for Misbranded Products
Silver Spring, MD—FDA has issued a warning letter to Whole Foods Market for engaging in a pattern of receiving and offering for sale misbranded...
Sports Nutrition Manufacturer Pleads Guilty to Distribution of Unapproved New Drugs
Apex, NC—A North Carolina resident and his sports nutrition company have pled guilty to a felony charge relating to the introduction of unapproved new...
CRN Responds to NAC Letters, New Proposed Rule
Washington, D.C.—The Council for Responsible Nutrition (CRN) has submitted comments regarding two separate issues: N-acetyl-L-cysteine (NAC) warning letters, and a recent proposed rule from...
NPA Says New AMA Policy Ignores Safety Record of Supplements
Washington, D.C.—A new policy announced by the American Medical Association (AMA) is calling for increased regulation of nutritional supplements in a policy that the...
MenaquinGold Receives FDA “No Question” Letter
Synergia Life Sciences has received an FDA “No Question” letter in response to a GRAS Notification for the intended use of the MenaquinGold brand...
